Viscera Technologies

London, United Kingdom MedTech, Diagnostics, Healthcare, antibiotic resistance, Oncology

Short Summary

At Viscera, our mission is to enable preventative treatments through predictive diagnostics. We are developing an innovative diagnostic test for H. pylori which will replace current clinical alternatives and act as a gastric cancer screening method.

Highlights

  • We have a working prototype
  • We have an experienced team of industry veterans
  • Strong claim on IP
  • Already large market with few recent innovations
  • Potential for market size to increase drastically with the right technology

Overview

Target
£70,000
Minimum
£5,000
Invested
n/a
Previous Rounds £40,000
Stage Pre-Startup/R&D
Investor Role Any
Please Note: Investments of this nature carry risks to your capital as well as potential rewards. Please read our Risk Warning and Disclaimer before deciding to invest.

Sign up or log in now

Sign up now to gain full access to pitches and investor profiles

global:publish_msg_immediate




global:publish_msg



Congratulations!


You have passed the test and you may continue your with your investment.